Heterogeneity of clinical manifestation of hypertrophic cardiomyopathy caused by deletion of lysine 183 in cardiac troponin I gene: Insight from two autopsy cases with an identical sarcomeric gene mutation

International Heart Journal

Volumn 51, Issue 3, 2010, Pages 214-217

  Funada, Akira ^a   Masuta, Eiichi ^a   Fujino, Noboru ^a   Hayashi, Kenshi ^a   Ino, Hidekazu ^a   Kita, Yoshihito ^b   Ikeda, Hiroko ^a   Fujii, Takahiko ^a   Nakanuma, Yasuni ^a   Yamagishi, Masakazu ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Wajima Municipal Hospital   (Japan)

Author keywords

Dilated phase of hypertrophic cardiomyopathy; Fibrosis; Histology

Indexed keywords

LYSINE; TROPONIN I;

AGED; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; ENVIRONMENTAL FACTOR; FEMALE; GENE DELETION; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM; HEREDITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; COMPLICATION; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENETICS; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; FEMALE; GENETIC HETEROGENEITY; HUMANS; MALE; SEQUENCE DELETION; TROPONIN I;

EID: 77954985787     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.214     Document Type: Article

References (19)

1. Kokado H, Shimizu M, Yoshio H, et al. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 2000; 102: 663-9.
2. Kimura A, Harada H, Park JE, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379-82.
3. Shimizu M, Ino H, Okeie K, et al. Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomy-opathy caused by a cardiac troponin I gene mutation. Am Heart J 2002; 143: 690-5.
4. Hughes SE. The pathology of hypertrophic cardiomyopathy. Histopathology 2004; 44: 412-27. (Review)
5. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomy-opathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107: 2227-32.
6. Kimura A. Molecular etiology and pathogenesis of hereditary cardiomyopathy. Circ J 2008; 72: A38-48. (Review)
7. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-9.
8. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998; 81: 1339-44. (Review)
9. Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profle, and signifcance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006; 114: 216-25.
10. Fujiwara H, Onodera T, Tanaka M, et al. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage. Jpn Circ J 1984; 48: 1210-4.
11. Unverferth DV, Baker PB, Pearce LI, Lautman J, Roberts WC. Regional myocyte hypertrophy and increased interstitial myo-cardial fbrosis in hypertrophic cardiomyopathy. Am J Cardiol 1987; 59: 932-6.
12. Yutani C, Imakita M, Ishibashi-Ueda H, et al. Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy. Am Heart J 1985; 109: 545-53.
13. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardio-myopathy. J Am Coll Cardiol 1986; 8: 545-57.
14. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: the interrelation of disarray, fbrosis, and small vessel disease. Heart 2000; 84: 476-82.
15. Shimizu M, Ino H, Yamaguchi M, et al. Autopsy findings in siblings with hypertrophic cardiomyopathy caused by Ar-g92Trp mutation in the cardiac troponin T gene showing dilated cardiomyopathy-like features. Clin Cardiol 2003; 26: 536-9.
16. Fujino N, Shimizu M, Ino H, et al. Cardiac troponin T Ar-g92Trp mutation and progression from hypertrophic to dilated cardiomyopathy. Clin Cardiol 2001; 24: 397-402.
17. Lechin M, Quiñones MA, Omran A, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92: 1808-12.
18. Osterop AP, Kofflard MJ, Sandkuijl LA, et al. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension 1998; 32: 825-30.
19. Thaman R, Gimeno JR, Murphy RT, et al. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart 2005; 91: 920-5.